Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib
Conclusion: Chinese cancer patients have a relatively lower frequency of METex14 alterations compared to Western patients. Patients with METex14 alterations showed distinct molecular characteristics and the representative case study showed responses to MET tyrosine kinase inhibitor (TKI).
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Tianli Cheng, Zhongping Gu, Danni Song, Sisi Liu, Xiaoling Tong, Xue Wu, Zhifeng Lin, Wei Hong Tags: Research Paper Source Type: research